ReviewTherapeutic advances in chronic disease2016

Ponesimod, a selective S1P1 receptor modulator: a potential treatment for multiple sclerosis and other immune-mediated diseases.

Daniele D'Ambrosio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.